User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial

Bibliographic reference Tabernero, Josep ; Lenz, Heinz-Josef ; Siena, Salvatore ; Sobrero, Alberto ; Falcone, Alfredo ; et. al. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial. In: The Lancet Oncology, Vol. 16, no. 8, p. 937-948 (2015)
Permanent URL http://hdl.handle.net/2078.1/164344